WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'7601 Infant (under 12 months) mortality rate: 432
GDP / capita (US$): 4'0861 Child (under 5 years) mortality rate: 642

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 16'212  15'721  15'246  14'787  14'344  10'585  8'143  5'929 
Births 645  631  619  607  595  468  377  285 
Surviving infants 613  598  585  572  560  422  334  256 
Pop. less than 5 years 2'851  2'788  2'732  2'678  2'621  1'917  1'540  1'170 
Pop. less than 15 years 7'444  7'246  7'053  6'863  6'675  4'923  3'864  2'855 
Female 15-49 years 3'733  3'603  3'476  3'355  3'240  2'381  1'801  1'278 

Number of reported cases

(Click for retrospective incidence data for Zambia)
Diphtheria
ChartChart
  12 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  35  896  13'234  30'930  6'748  98'659 
Mumps
ChartChart
  6'213 
Pertussis
ChartChart
  200  21'232 
Polio*
ChartChart
  79  276 
Rubella
ChartChart
  94  74  183  134  1'124 
Rubella (CRS)
ChartChart
  10 
Tetanus (neonatal)
ChartChart
  130  57 
Tetanus (total)**
ChartChart
  193  57  409 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zambia)
Vaccine year result method % card seen                                                
BCG 2013  95  DHS   80  97  95  82  83  88  99*  97 
DTP1 2013  96  DHS   80  97  96  86  86  87  93 
DTP3 2013  86  DHS   80  90  86  79  78  81  76  71 
DTP4         
IPV1         
HepB_BD         
HepB3 2013  86  DHS   80  90  86  79  78  81 
Hib3 2013  86  DHS   80  90  86  79  78  81 
JapEnc         
MCV1          90  85  80  95  83  85  68 
MCV2          47  33 
PCV1          94  89 
PCV3          81  77 
Pol3 2013  78  DHS   80  90  78  74  70  83  79  70 
Rota1          90  80 
RotaC         
Rubella1         
TT2plus 2013  30  DHS   80  75  74  74  71  74  61 
PAB         
VAD1          90  99*  99*  59  99* 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zambia)
BCG
ChartChart
  95  95  92  92  94  97 
DTP1
ChartChart
  96  86  86  87  94  97 
DTP3
ChartChart
  86  79  78  81  85  91 
HepB3
ChartChart
  86  79  78  81 
HepB_BD
ChartChart
 
Hib3
ChartChart
  86  79  78  81 
MCV1
ChartChart
  85  80  82  83  85  90 
MCV2
ChartChart
  33 
PAB
ChartChart
  85  81  81  81  78  62 
PCV3
ChartChart
  77 
Pol3
ChartChart
  78  74  70  83  85  90 
RotaC
ChartChart
  73 

Number of districts in the country 103  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 19
From 50 to 79% 23
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +2, +4 months; No Demonstration project
IPV 14 weeks; Yes From September 2016
MR 9, 18 months; Yes From September 2016
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact pregnancy; +1, +1, +6 months; +1, +1 years; Yes pregnant women and CBAW
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2011-2015  2011-2015  2011-2015  2010 - 2014  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number   105  72  72  72  72   

System performance

Total Nº districts in country number 74  74  72  72  72  72  72 
Nº districts with DTP3 coverage >=80% number 61  39  50  45  49  62  55 
% of districts with DTP3 coverage >=80% From 0 to 100% 82  53  69  63  68  86  76 
Nº districts with measles (MCV1) coverage >=95% number 25  15  37  25  42  32  23 
% of districts with MCV1 coverage >=95% From 0 to 100% 34  20  51  35  58  44  32 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes    Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes    Yes  Yes  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 33  69    69       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.